IPG Photonics to Announce Third Quarter 2024 Financial Results on October 29
October 15, 2024 08:00 ET
|
IPG Photonics Corporation
MARLBOROUGH, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (Nasdaq: IPGP) will release its third quarter 2024 financial results before the market opens on Tuesday, October 29,...
Patria Announces Third Quarter 2024 Investor Call
October 10, 2024 16:30 ET
|
Patria Investments Limited
GRAND CAYMAN, Cayman Islands, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Patria (Nasdaq:PAX) announced today that it will release financial results for the third quarter 2024 on Tuesday, November 5, 2024,...
Innospec Schedules Third Quarter 2024 Earnings Release and Conference Call
October 07, 2024 16:45 ET
|
Innospec Inc.
ENGLEWOOD, Colo., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release third quarter 2024 earnings results on Tuesday, November 5, 2024 after market...
InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2024
September 10, 2024 16:05 ET
|
InnovAge
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR ENDED JUNE 30, 2024
Agrify Corporation Announces Results for Second Quarter 2024 and Amended Results for First Quarter 2024
August 14, 2024 16:35 ET
|
Agrify
Agrify Corporation Announces Results for Second Quarter 2024 and Amended Results for First Quarter 2024
OMNIQ Schedules Second-Quarter 2024 Earnings Call
August 13, 2024 08:30 ET
|
omniQ Corp.
OMNIQ schedules second-quarter earnings release followed by a live earnings call with management on August 15, 2024.
Rumble Reports Second Quarter 2024 Results
August 12, 2024 16:05 ET
|
Rumble, Inc.
~ Delivers Sequential Revenue Growth of 27% to $22.5 Million ~ ~ Introduces New KPI, Average Revenue Per User (ARPU), Up 19% Over First Quarter ~ LONGBOAT KEY, Fla., Aug. 12, 2024 (GLOBE...
Niu Technologies Announces Unaudited Second Quarter 2024 Financial Results
August 12, 2024 03:00 ET
|
NIU Technologies
-- Second Quarter Revenues of RMB 940.5 million, an increase of 13.5% year-over-year -- Second Quarter Net Loss of RMB 24.9 million, compared to Net Loss of RMB 1.9 million in the same period...
Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments
August 09, 2024 08:00 ET
|
Monopar Therapeutics Inc.
Initiated and Enrolling Patients into MNPR-101-Zr First-in-Human Phase 1 Radiopharma Clinical Trial MNPR-101 radio-immuno-therapeutic (RIT) Clinical Trial on Track to Initiate in Q4 2024 ...
HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
August 08, 2024 19:20 ET
|
HilleVax, Inc.
$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024 The company is exploring the potential for continued development of its HIL-214 and HIL-216 norovirus vaccine...